National Breast and Ovarian Cancer Centre

Research summary

March 2007

Obesity and risk of epithelial ovarian cancer

Summary

A systematic review and meta-analysis of 28 studies has found an association between obesity and the risk of epithelial ovarian cancer.

Australian researchers have reported the results of a meta-analysis in the March 2007 issue of European Journal of Cancer. All eligible studies assessed the association between overweight, obesity and ovarian cancer. ‘Overweight’ was defined as having a body mass index (BMI) of 25-29.9. ‘Obesity’ was defined as having a BMI of 30 or more.

The researchers found consistent evidence that the risk of ovarian cancer increases with increasing BMI. They estimated that the risk of epithelial ovarian cancer among obese women may be 30 per cent higher than women with a BMI in the ‘healthy range’ (18.5-24.9). The risk for overweight women was less than for obese women, but may still be 16 per cent higher than women with a ‘healthy’ BMI.

The researchers concluded that obesity in adulthood is a modest but statistically significant risk factor for ovarian cancer, suggesting that ovarian cancer should be added to the list of cancers likely to be related to obesity.

National Breast Cancer Centre comment

This meta-analysis adds to a body of work on the association between obesity and cancer, which is of increasing public health significance given the current rates of obesity in Australia.

Obesity is an established risk factor for several hormone-related cancers, including post-menopausal breast cancer and endometrial cancer, but until now the evidence for an effect on risk of ovarian cancer has been inconclusive.

In contrast with other known risk factors for ovarian cancer, such as increasing age and a family history of the disease, obesity is one risk factor that is potentially modifiable.

Back to Top

Annual Report 2006 - 2007

Download the Annual Report from the National Breast and Ovarian Cancer Centre (NBOCC).

Mission

National Breast and Ovarian Cancer Centre will play a lead role in national cancer control and in improving cancer care, through an evidence-based approach to informing best practice, health systems reform and policy.

Vision

To reduce mortality and improve the wellbeing of those diagnosed with breast or ovarian cancer.

National Breast and Ovarian Cancer Centre - making a difference in women’s health

This site is proudly supported and hosted by the University of Sydney's Faculty of Medicine